Genetics

It is game over for 23andMe, and rightly so

The market for personal genome services is facing a reality check. While the most prominent and innovative company 23andMe has flourished so far, in the past few years many of its competitors have gone out of business. Now, ...

Oncology & Cancer

Measuring hormones could help improve breast cancer risk prediction

Including the levels of several hormones in currently used breast cancer risk prediction models improves prediction, and this could help better identify women who would benefit from chemoprevention, according to results presented ...

Psychology & Psychiatry

Functional outcome explored in those at risk for psychosis

(HealthDay)—Measures of social and role functioning predict functional outcome in those at clinical high risk for psychosis, and poor functional outcome is not entirely dependent on conversion to full-blown disease, according ...

Cardiology

USPSTF: evidence lacking for ankle brachial index screening

(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has found that there is currently insufficient evidence to weigh the benefits and harms of use of the ankle-brachial index (ABI) for screening for peripheral ...

Diseases, Conditions, Syndromes

'Risk calculator' developed for venous thromboses

In Austria, around 15,000 people a year develop a venous thrombosis, the occlusion of a vein that can result in a pulmonary embolism. A clot breaks free from a vein and travels via the bloodstream to the lungs, where it blocks ...

page 6 from 10